1435.1 - Processing and Cryopreservation of Male and Female Gonadal Tissue and Gametes Prior to or after Gonadotoxic Treatment to Preserve Fertility for the Future

Page last updated: 01 April 2019

Application Detail

Status

Open

Description of Medical Service

The Applicant is seeking a review of the following proposed medical services:

Processing and handling of ovarian tissue in preparation for cryostorage as part of fertility preservation treatment for female patients who have or will receive gonadotoxic treatment.

Processing and handling of semen in preparation for cryostorage as part of fertility preservation treatment for male patients who have or will receive gonadotoxic treatment.

Processing and handling of testicular tissue in preparation for cryostorage as part of fertility preservation treatment for male patients who have or will receive gonadotoxic treatment.

Description of Medical Condition

The proposed patient population is defined by the requirement of gonadotoxic therapy. Two distinct patient populations may be defined:
  1. Patients diagnosed with malignancy
  2. Patients diagnosed with non-malignant conditions receiving gonadotoxic treatment

Reason for Application

Re-submission

Medical Service Type

Therapeautic

Previous Application Number

1435

Associated Documentation

Application Form

-

Consultation Survey

Feedback and comments are welcome at any stage during the MSAC process. Please provide comments on Application 1435.1 via a maximum of two A4 pages to HTA@health.gov.au (making sure that you type the application number at the start of your comments and in the subject heading of your email).

PICO Confirmation

-

Assessment Report

-

Public Summary Document

-

Meetings for this Application

PASC

-

ESC

13 June 2019

MSAC

-